Search

Author/Creator Faia, Kerrie

1. Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study. Issue 11 (20th October 2018)

Authors:
O'Brien, Susan; Patel, Manish; Kahl, Brad S.; Horwitz, Steven M.; Foss, Francine M.; Porcu, Pierluigi; Jones, Jeffrey; Burger, Jan; Jain, Nitin; Allen, Kerstin; Faia, Kerrie; Douglas, Mark; Stern, Howard M.; Sweeney, Jennifer; Kelly, Patrick; Kelly, Virginia; Flinn, Ian
Journal:
American journal of hematology
Issue:
Volume 93:Issue 11(2018:Nov.)
Page Start:
1318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway. (25th March 2013)

Authors:
Smith, Sherri; Hoyt, Jennifer; Whitebread, Nigel; Manna, Joseph; Peluso, Marisa; Faia, Kerrie; Campbell, Veronica; Tremblay, Martin; Nair, Somarajan; Grogan, Michael; Castro, Alfredo; Campbell, Matthew; Ferguson, Jeanne; Arsenault, Brendan; Nevejans, Jylle; Carter, Bennett; Lee, John; Dunbar, Joi...
Journal:
Xenobiotica
Issue:
Volume 43:Number 10(2013:Oct.)
Page Start:
875
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search